» Articles » PMID: 35128756

Psychosocial Impact of Testing Human Papillomavirus Positive in Australia's Human Papillomavirus-based Cervical Screening Program: A Cross-sectional Survey

Overview
Journal Psychooncology
Publisher Wiley
Specialties Oncology
Psychology
Date 2022 Feb 7
PMID 35128756
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: To examine the impact of self-reported human papillomavirus (HPV) test result (HPV negative, HPV positive, HPV result unknown) on a range of psychosocial outcomes.

Methods: Women and other people with a cervix in Australia aged 25-74 years who reported having participated in cervical screening since December 2017 were recruited through Facebook and Instagram to complete an online survey. The primary outcome measures were anxiety, emotional distress, and general distress.

Results: Nine hundred fifteen participants completed the online survey; 73.2% reported testing HPV negative ('HPV-'), 15% reported testing HPV positive ('HPV+') and 11.8% reported that they did not know/remember their test result ('HPV unknown'). Compared to participants testing HPV-, participants testing HPV+ had higher mean anxiety (41.67 vs. 37.08, p < 0.001) and emotional distress scores (11.88 vs. 7.71, p < 0.001). Concern about test result (34.3% vs. 1.3%, p < 0.001), perceived risk compared to average women (55.4% vs. 14.1%, p < 0.001), and cancer worry (27.8% vs. 5.9%, p < 0.001) were also greater among HPV+ participants than participants testing HPV-. Participants testing HPV+ felt less reassured about their screening result than participants testing HPV- (16% vs. 75.1%, p < 0.001). Participants testing HPV+ had greater knowledge of HPV (11.96 vs. 10.36 out of 16, p < 0.001) and HPV testing (3.94 vs 3.28 out of 5, p < 0.001) than participants who reported testing HPV-.

Conclusions: Elevated levels of anxiety and emotional distress were found in those testing HPV+ compared with those testing HPV-. Future research should examine what strategies should be used to deliver test results and what additional information is provided, in order to alleviate anxiety among individuals testing HPV+.

Citing Articles

Analysis of risk factors associated with cervical HPV infection and their effects on female sexual function and anxiety: a multicenter cross-sectional study based on Chinese women.

Wang H, Nie K, Liu Z, Zhao Y, Ha Y, Zhang H Front Oncol. 2024; 14:1468160.

PMID: 39512769 PMC: 11540700. DOI: 10.3389/fonc.2024.1468160.


Sexual Function and Quality of Life in Iranian Women With Human Papillomavirus Infection.

Tehranian A, Dastjerdi M, Hatamian S, Ghahghaei-Nezamabadi A J Family Reprod Health. 2024; 18(3):154-159.

PMID: 39439738 PMC: 11491696. DOI: 10.18502/jfrh.v18i3.16656.


Investigating the psychometric properties of the Persian version of the Quality of Life Questionnaire for Women Infected with HPV (EQUALI-HPV).

Arashlouei A, Maghsoudi S, Irani M, Honarvar Z, Ahmadi A, Pereira-Caldeira N BMC Public Health. 2024; 24(1):2464.

PMID: 39256729 PMC: 11389061. DOI: 10.1186/s12889-024-19954-0.


The Impact of HPV Diagnosis and the Electrosurgical Excision Procedure (LEEP) on Mental Health and Sexual Functioning: A Systematic Review.

Sikorska M, Pawlowska A, Antosik-Wojcinska A, Zygula A, Suchonska B, Dominiak M Cancers (Basel). 2023; 15(8).

PMID: 37190155 PMC: 10136821. DOI: 10.3390/cancers15082226.


The psychological impact of esophageal cancer screening on anxiety and depression in China.

Zhu J, Ma S, Chen R, Liu Z, Liu Z, Wei W Front Psychiatry. 2022; 13:933678.

PMID: 36339848 PMC: 9630588. DOI: 10.3389/fpsyt.2022.933678.


References
1.
Kensinger E . Remembering the Details: Effects of Emotion. Emot Rev. 2009; 1(2):99-113. PMC: 2676782. DOI: 10.1177/1754073908100432. View

2.
Chadwick V, Bennett K, McCaffery K, Brotherton J, Dodd R . Psychosocial impact of testing human papillomavirus positive in Australia's human papillomavirus-based cervical screening program: A cross-sectional survey. Psychooncology. 2022; 31(7):1110-1119. PMC: 9546150. DOI: 10.1002/pon.5897. View

3.
Dodd R, Mac O, McCaffery K . Women's experiences of the renewed National Cervical Screening Program in Australia 12 months following implementation: a qualitative study. BMJ Open. 2020; 10(7):e039041. PMC: 7359067. DOI: 10.1136/bmjopen-2020-039041. View

4.
Marlow L, McBride E, Ridout D, Forster A, Kitchener H, Waller J . Patterns of anxiety and distress over 12 months following participation in HPV primary screening. Sex Transm Infect. 2021; 98(4):255-261. PMC: 9120391. DOI: 10.1136/sextrans-2020-054780. View

5.
Hersch J, Barratt A, Jansen J, Irwig L, McGeechan K, Jacklyn G . Use of a decision aid including information on overdetection to support informed choice about breast cancer screening: a randomised controlled trial. Lancet. 2015; 385(9978):1642-52. DOI: 10.1016/S0140-6736(15)60123-4. View